Brand Reference: Lexapro
| Metric | Verified Benchmark | Source |
|---|---|---|
| Escitalopram Oxalate (Pure S-Enantiomer SSRI) RxNorm Concept ID | 321988 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0360 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $42.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $5.10 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $6.50 / mo | 56 Zero-PHI Verified Patient Logs |
Isolated S-stereoisomer of citalopram that binds both the orthosteric primary serotonin transporter (SERT) pocket and its low-affinity allosteric vestibule (unhindered by R-citalopram interference), locking SERT inhibition for highest serotonergic selectivity and minimal CYP interaction.
For self-pay patients filling Escitalopram Oxalate (Pure S-Enantiomer SSRI) (NDC 00378-3856-93), direct wholesale and telehealth fulfillment drops monthly spend from $42.00 retail to $5.10 (88% savings against a $0.0360 CMS pharmacy acquisition baseline).
Clinical clearance of Escitalopram Oxalate (Pure S-Enantiomer SSRI) (Allosterically Stabilized Selective Serotonin Reuptake Inhibitor (SSRI)) relies on hepatic cyp2c19 and cyp3a4 demethylation to s-dct with a 27–32 hours half-life; patients absorbing at 80% oral bioavailability typically observe target onset around 2–4 weeks mood & somatic anxiety remission.
FDA clinical labeling for Escitalopram Oxalate (Pure S-Enantiomer SSRI) restricts administration in maoi or linezolid/methylene blue within 14 days; pimozide or congenital qt prolongation across 5 mg PO daily (week 1), 10 mg PO once daily, 20 mg PO once daily, with self-reported patient tracking dominated by delayed orgasmic latency (28% of reports), week-1 mild nausea (16% of reports), emotional blunting at 20 mg (14% of reports).
Across 56 verified cash-pay logs, Escitalopram Oxalate (Pure S-Enantiomer SSRI) achieves a 87.40% Worth-It rating with out-of-pocket spend averaging $6.50/mo versus $42.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 5 mg PO daily (week 1) for Escitalopram Oxalate (Pure S-Enantiomer SSRI); monthly out-of-pocket dropped to $4.50 compared with $42.00 retail.
Completed 10 weeks on Escitalopram Oxalate (Pure S-Enantiomer SSRI) (10 mg PO once daily). Zero notable side effects on steady dosing.
Consistent biomarker response on 20 mg PO once daily Escitalopram Oxalate (Pure S-Enantiomer SSRI) sourced via TeleMed ($5.92/mo cash pay without insurance prior authorization).